Trials / Unknown
UnknownNCT03214393
Certain Maternal Antibodies in Relation to Doppler in Hypertension With Pregnancy
Role of Maternal Anticardiolipin and Anti-B2 Glycoprotein I Antibodies in Correlation With Fetal Doppler in Prediction of Adverse Pregnancy Outcome in Patients With Preeclampsia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Relation of certain maternal serum antibodies to Doppler changes will be studied in cases suffering from hypertension with pregnancy.
Detailed description
Assessment will be done for maternal serum anti-beta 2 glycoprotein 1 antibodies and anticardiolipin antibodies in cases of preeclampsia after 32 weeks of pregnancy. In addition, fetal Doppler changes will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Doppler | Doppler will be done to pregnant women with Pre-Eclampsia |
| DIAGNOSTIC_TEST | serum antibodies | serum antibodies will be measured for pregnant women with Pre-Eclampsia |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-07-30
- Completion
- 2018-08-30
- First posted
- 2017-07-11
- Last updated
- 2017-07-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03214393. Inclusion in this directory is not an endorsement.